A report contained claims it is inappropriate but it is exactly how the system is designed to work - financial incentives to encourage the dispensing of biosimilars are contingent on and subordinated to clinical judgement. …
The system subordinates the pharmacist's choice to that of the clinician
October 11, 2021 Latest NewsBioPharma
Latest Video
Georgia Forrest
New Stories
-
GBMA moves to reclaim the reform agenda with a focus on pricing and supply
February 5, 2026 - - Latest News -
Nuclear medicine sector argues for dedicated scheme to unlock cancer therapies
February 4, 2026 - - Latest News -
Pfizer’s once-monthly weight-loss injection delivers strong mid-stage results
February 4, 2026 - - Latest News -
GBMA Summit focuses on access, affordability and security in an uncertain world
February 4, 2026 - - Latest News -
Medicines Australia calls for Budget action to restore access to innovative medicines
February 3, 2026 - - Latest News -
Survey exposes deep gaps in support for Australians living with rare cancers
February 3, 2026 - - Latest News -
Juvenile Arthritis Foundation Australia seeks new CEO as Angela McKay steps down
February 3, 2026 - - Latest News